Issues related to drug pricing reform H.R.5376, Build Back Better Act S2891 Restoring America Invents Act S1435 affordable prescriptions for patients act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to clinical trial diversity, HR 6584 DEPICT Act, HR5030 DIVERSE Trials Act, HR 7845 and S2706 NIH Clinical Trial Diversity Act of 2022 Issues related to biodefense issues, S3799 PREVENT Pandemics Act Issues related to cardiovascular disease awareness, S. 3018/ HR 3173 Improving Seniors Timely Access to Care Act, S.464 Safe Step Act and HR8295 Labor/HHS Appropriations bill H.R. 5801 HELP Copays Act Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters FDA Issues; User Fee Reauthorization HR7667 Food and Drug Amendments Act and S4348 FDA safety and landmark advancement act H.R. 6963, the Accelerated Approval Integrity Act of 2022 H.R. 7047, a bill to amend Title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes H.R. 6000, the Cures 2.0 Act H.R. 7008, the Pre-Approval Information Exchange Act S4293 Pharmacy benefit managers transparency act HR 8588Fair Care Act, 340B hospital reporting HR 4390 Protect 340B Act Issues related to drug pricing reform and Medicare Part D redesign H.R. 5376 Build Back Better Act S. 1943 and H.R. 3517, Issues related to DXA scans, osteoporosis issues related to cardiovascular disease awareness Issues related to ESRD bundle Issues related to asthma and self-administered drug list S. 2428 False Claims Amendments Act of 2021 Reimbursement for biologics/biosimilars Issues related to discarded drugs Issues related to corporate and international tax, including regarding Public Law 115-97, Tax Cuts and Jobs Act Issues related to Puerto Rico Final Rule, Guidance Related to the Foreign Tax Credit and Clarification of Foreign-Derived Intangible Income Issues related to OECD negotiations on the taxation of global income H.R. 5376, Bill to provide for reconciliation pursuant to title I of S. Con. Res. 14 S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S 2891 Restore the America Invents Act S. 2774- Pride in Patent Ownership Act S. 4704- Patent Examination and Quality Improvement Act of 2022 S. 4417- Patent Trial and Appeal Board Reform Act of 2022 S. 4430- Interagency Patent Coordination and Improvement Act of 2022 FTC related issues, no specific bill Issues related to the Patent Act Issues related to march-in/Bayh Dole, WTO/TRIPS waiver, no specific bill Mergers and acquisitions, no specific bill
HCR - Health Issues MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AMGEN, INC.
601 13th Street, NW, 11th Floor North, WASHINGTON, DC, 20005, US
WILLIAM O'BRIEN HELEN RHEE JESSE KERNS L NICOLE CURRIE GREGORY PORTNER VICTORIA BLATTER HOWARD MOON RUTH HOFFMAN JORDAN LYNN LAYSON WINTA MENGHIS KIMBERLY LOVE L NICOLE CURRIE GREGORY PORTNER HELEN RHEE JESSE KERNS VICTORIA BLATTER WILLIAM O'BRIEN HOWARD MOON RUTH HOFFMAN JORDAN LYNN LAYSON WINTA MENGHIS KIMBERLY LOVE L NICOLE CURRIE HELEN RHEE JORDAN LYNN LAYSON VICTORIA BLATTER HELEN RHEE GREGORY PORTNER L NICOLE CURRIE WILLIAM O'BRIEN VICTORIA BLATTER HOWARD MOON JESSE KERNS JORDAN LYNN LAYSON KIMBERLY LOVE